Literature DB >> 33232279

Identification of prognostic aging-related genes associated with immunosuppression and inflammation in head and neck squamous cell carcinoma.

Jing Yang1,2, Qingshan Jiang3, Lijun Liu3, Hong Peng3, Yaya Wang3, Shuyan Li3, Yanhua Tang3, Jing Yu3, Runliang Gan2, Zhifeng Liu3.   

Abstract

Aging is regarded as a dominant risk factor for cancer. Additionally, inflammation and asthenic immune surveillance with aging may facilitate tumor formation and development. However, few studies have comprehensively analyzed the relationship between aging-related genes (AGs) and the prognosis, inflammation and tumor immunity of head and neck squamous cell carcinoma (HNSCC). Here, we initially screened 41 differentially expressed AGs from The Cancer Genome Atlas (TCGA) database. In the training set, a prognosis risk model with seven AGs (APP, CDKN2A, EGFR, HSPD1, IL2RG, PLAU and VEGFA) was constructed and validated in the TCGA test set and the GEO set (P < 0.05). Using univariate and multivariate Cox regression analyses, we confirmed that risk score was an independent prognostic factor of HNSCC patients. In addition, a high risk score was significantly correlated with immunosuppression, and high expression of PLAU, APP and EGFR was the main factor. Furthermore, we confirmed that a high risk score was significantly associated with levels of proinflammatory factors (IL-1α, IL-1β, IL-6 and IL-8) in HNSCC samples. Thus, this risk model may serve as a prognostic signature and provide clues for individualized immunotherapy for HNSCC patients.

Entities:  

Keywords:  aging-related genes (AGs); head and neck squamous cell carcinoma (HNSCC); immunosuppression; inflammation; prognosis

Mesh:

Substances:

Year:  2020        PMID: 33232279      PMCID: PMC7803584          DOI: 10.18632/aging.104199

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  56 in total

Review 1.  The amyloid precursor protein (APP) processing as a biological link between Alzheimer's disease and cancer.

Authors:  Fernando Galvão; Kamila Castro Grokoski; Bruno Batista da Silva; Marcelo Lazzaron Lamers; Ionara Rodrigues Siqueira
Journal:  Ageing Res Rev       Date:  2018-11-27       Impact factor: 10.895

2.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

3.  CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer.

Authors:  Sayantan Bhattacharyya; Vasanthakumar Sekar; Biswanath Majumder; Debapriya G Mehrotra; Samir Banerjee; Anup K Bhowmick; Neyaz Alam; Gautam K Mandal; Jaydip Biswas; Pradip K Majumder; Nabendu Murmu
Journal:  Cell Oncol (Dordr)       Date:  2016-12-30       Impact factor: 6.730

4.  Predictive Potential of Head and Neck Squamous Cell Carcinoma Organoids.

Authors:  Sarah J Hill; Alan D D'Andrea
Journal:  Cancer Discov       Date:  2019-07       Impact factor: 39.397

5.  The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death.

Authors:  Chiara Pozzi; Alessandro Cuomo; Ilaria Spadoni; Elena Magni; Alessio Silvola; Alexia Conte; Sara Sigismund; Paola Simona Ravenda; Tiziana Bonaldi; Maria Giulia Zampino; Carlotta Cancelliere; Pier Paolo Di Fiore; Alberto Bardelli; Giuseppe Penna; Maria Rescigno
Journal:  Nat Med       Date:  2016-05-02       Impact factor: 53.440

6.  ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.

Authors:  Qi Zhang; Sihong Lu; Tianfu Li; Liang Yu; Yunjian Zhang; Huijuan Zeng; Xueke Qian; Jiong Bi; Ying Lin
Journal:  J Exp Clin Cancer Res       Date:  2019-04-25

7.  HSPD1 repressed E-cadherin expression to promote cell invasion and migration for poor prognosis in oral squamous cell carcinoma.

Authors:  Bor-Hwang Kang; Chih-Wen Shu; Jian-Kang Chao; Cheng-Hsin Lee; Ting-Ying Fu; Huei-Han Liou; Luo-Ping Ger; Pei-Feng Liu
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

8.  CircRhoC promotes tumorigenicity and progression in ovarian cancer by functioning as a miR-302e sponge to positively regulate VEGFA.

Authors:  Li-Li Wang; Zhi-Hong Zong; Yao Liu; Xue Guan; Shuo Chen; Yang Zhao
Journal:  J Cell Mol Med       Date:  2019-10-22       Impact factor: 5.310

9.  Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer.

Authors:  L K Nottingham; C H Yan; X Yang; H Si; J Coupar; Y Bian; T-F Cheng; C Allen; P Arun; D Gius; L Dang; C Van Waes; Z Chen
Journal:  Oncogene       Date:  2013-03-04       Impact factor: 9.867

10.  BCR-Induced Ca2+ Signals Dynamically Tune Survival, Metabolic Reprogramming, and Proliferation of Naive B Cells.

Authors:  Corbett T Berry; Xiaohong Liu; Arpita Myles; Satabdi Nandi; Youhai H Chen; Uri Hershberg; Igor E Brodsky; Michael P Cancro; Christopher J Lengner; Michael J May; Bruce D Freedman
Journal:  Cell Rep       Date:  2020-04-14       Impact factor: 9.423

View more
  10 in total

1.  The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.

Authors:  Fang Chen; Xin Gong; Meng Xia; Feng Yu; Jian Wu; Chaosheng Yu; Junzheng Li
Journal:  Front Oncol       Date:  2022-05-10       Impact factor: 5.738

2.  Development of an Aging-Related Gene Signature for Predicting Prognosis, Immunotherapy, and Chemotherapy Benefits in Rectal Cancer.

Authors:  Yangyang Wang; Yan Liu; Chunchao Zhu; Xinyu Zhang; Guodong Li
Journal:  Front Mol Biosci       Date:  2022-01-10

3.  Identification of an Aging-Related Gene Signature in Predicting Prognosis and Indicating Tumor Immune Microenvironment in Breast Cancer.

Authors:  Wenchang Lv; Chongru Zhao; Yufang Tan; Weijie Hu; Honghao Yu; Ning Zeng; Qi Zhang; Yiping Wu
Journal:  Front Oncol       Date:  2021-12-16       Impact factor: 6.244

4.  Depiction of Aging-Based Molecular Phenotypes With Diverse Clinical Prognosis and Immunological Features in Gastric Cancer.

Authors:  Fang He; Huan Ding; Yang Zhou; Yuanzhen Wang; Juan Xie; Shaoqi Yang; Yongzhao Zhu
Journal:  Front Med (Lausanne)       Date:  2022-02-01

5.  Characterization of Aging-Related Genes to Predict Prognosis and Evaluate the Tumor Immune Microenvironment in Malignant Melanoma.

Authors:  Ni Zeng; Chenrui Guo; Yajun Wang; Lin Li; Xi Chen; Shaoying Gao; Feng Jiang; Bilan Cao
Journal:  J Oncol       Date:  2022-03-24       Impact factor: 4.375

Review 6.  An Update on the Immunotherapy for Oropharyngeal Squamous Cell Carcinoma.

Authors:  Yaxuan Huang; Yunyun Lan; Zhe Zhang; Xue Xiao; Tingting Huang
Journal:  Front Oncol       Date:  2022-03-15       Impact factor: 6.244

7.  Comprehensive Characterization of Ageing-Relevant Subtypes Associated With Different Tumorigenesis and Tumor Microenvironment in Prostate Cancer.

Authors:  Liang Huang; Zhenzhou Xu; Yu Xie; Shusuan Jiang; Weiqing Han; Zhengyan Tang; Quan Zhu
Journal:  Front Mol Biosci       Date:  2022-02-21

8.  Identification of new head and neck squamous cell carcinoma subtypes and development of a novel score system (PGSscore) based on variations in pathway activity between tumor and adjacent non-tumor samples.

Authors:  Yufan Zhang; Ying Liu; Junfei Huang; Zhiqi Hu; Yong Miao
Journal:  Comput Struct Biotechnol J       Date:  2022-09-01       Impact factor: 6.155

9.  A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma.

Authors:  Yi Zhang; Ping Chen; Qiang Zhou; Hongyan Wang; Qingquan Hua; Jie Wang; Hongliang Zhong
Journal:  Front Genet       Date:  2021-06-18       Impact factor: 4.599

10.  Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.

Authors:  Bin Wang; Fachun Tong; Chengxi Zhai; Long Wang; Yunzan Liu; Jian Wang
Journal:  Dis Markers       Date:  2021-10-21       Impact factor: 3.434

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.